Advertisement

November 2017 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for November 2017. This roundup includes the latest...
The chemical stability of warfarin sodium tablets is not affected by repackaging into dose administration aids

Storage in Dose Administration Aids Doesn’t Affect Warfarin

0
Repackaging of warfarin sodium tablets into dose administration aids doesn't affect chemical stability
A decision pathway has been developed to guide management of acute bleeding in patients treated with oral anticoagulants; the decision pathway was published online Dec. 1 in the Journal of the American College of Cardiology.

ACC Guides Treatment of Bleeding With Oral Anticoagulation

0
Pathway supports clinician decision making during management of patients with bleeding complications
Eating raw almonds

Almonds With/Without Chocolate May Improve Lipid Profiles

0
Findings based on a small study assessing diet combinations in overweight people
More than half of today's children are expected to be obese at the age of 35 years

More Than Half Today’s Children Expected to Be Obese at 35

0
Relative risk of adult obesity increases with age and BMI, up to 3.10 for 19-year-olds with severe obesity
Among patients with diabetes

Severe Hypoglycemia a Potent Marker of Cardiovascular Risk

0
Findings based on long-term follow-up of patients with diabetes
Increased wait time is associated with an increased risk of complications and 30-day mortality among adults undergoing hip fracture surgery

Wait Time Linked to Worse Outcomes in Hip Fracture Surgery

0
Patients receiving surgery after 24 hours have higher risk of 30-day mortality, complications
Older adults report feeling confident that they know how to avoid drug interactions despite only 35 percent having spoken to someone about it in the past year

Many Seniors Have Not Discussed Avoiding Drug Interactions

0
69 percent of patients see multiple doctors, 21 percent use multiple pharmacies, complicating issue
Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) may help assess apparent resistance to PCSK9 inhibitors

Measuring Plasma PCSK9 May ID Resistance to PCSK9 Inhibitors

0
Most patients experience increase of at least 3.7-fold in plasma PCSK9 levels after treatment
The Value-Based Payment Modifier is not associated with performance differences between practices serving higher-risk and lower-risk patients

Value-Based Payment Modifier Not Tied to Practice Performance

0
Performance differences between practices narrowed after adjustment for patient characteristics